LENZ

LENZ THERAPEUTICS INC

LENZ·52635N103·US·Common Stock·Healthcare - Biotechnology-Activist

LENZ (LENZ THERAPEUTICS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($38.2M), FMR LLC ($32.9M), BlackRock, Inc. ($18.1M). Net institutional sentiment: Mixed.

92
Holders
Avg rating(18 Elite)
$206.2M
Total Value
60% (110)
Fund Consensus
59 buying - 39 selling
LENZSmart Money Verdict
View all
Held by 92 funds
18 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC5.1%Jun 26, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.8%Apr 27, 2026
ActivistSOSquarepoint Ops LLC5.1%Apr 8, 2026
InsiderSBSchimmelpennink Evert B.Buy $251KMar 27, 2026
InsiderCRChevallard Daniel R.Buy $64KMar 27, 2026
InsiderGPGeorge Jeffrey P.Buy $50KMar 27, 2026
ActivistRIRidgeback Capital Investments L.P.0.0%Feb 17, 2026
ActivistFMR LLCFMR LLC11.8%Feb 5, 2026
InsiderOSOlsson ShawnSell $108KNov 17, 2025
InsiderOSOlsson ShawnSell $153KNov 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
4.2M$38.2M0.4%-74.97%
0
Decreased
3.6M(-2.8%)$32.9M0.0%-65.86%
0
Increased
2M(+16.8%)$18.1M0.0%-78.81%
33
Increased
1.5M(+206.3%)$13.8M0.0%-64.41%
45
Increased
1.2M(+136.2%)$10.6M0.0%-66.56%
45
Increased
1.1M(+0.3%)$10.1M0.0%-82.15%
28
New
1M$9.5M0.0%-57.49%
38
Increased
869,257(+61.2%)$8M0.0%-62.72%
40
Increased
648,848(+178.0%)$5.9M0.0%-69.95%
44
Increased
547,534(+377.4%)$5M0.0%-70.88%
43
Increased
524,574(+13.8%)$4.8M0.0%-73.87%
31
Increased
500,997(+70.7%)$4.6M0.0%-69.53%
40
Increased
472,200(+26.9%)$4.3M0.0%-63.91%
33
Unchanged
463,495$4.2M0.0%-74.22%
0
Decreased
402,225(-21.3%)$3.7M0.0%-77.90%
0
Increased
283,206(+62.1%)$2.6M0.0%-62.69%
38
Increased
221,037(+157.7%)$2M0.0%-60.92%
42
Increased
214,408(+23.8%)$2M0.0%-64.05%
31
Increased
185,624(+14.7%)$1.7M0.0%-74.74%
29
Decreased
183,756(-28.8%)$1.7M0.0%-73.03%
0

Showing 1-20 of 110

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used